Evidence map›Paper›PMID 38953375›Full record

ArticlemBio2024

An efficient

Elisabet Bjånes, Alexandra Stream, Axel B Janssen, Paddy S Gibson, Afonso M Bravo, Samira Dahesh, Jonathon L Baker, Andrew Varble, Victor Nizet, Jan-Willem Veening

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Epigenomics identifies three sources of DNA methylation inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elisabet Bjånes *Department of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-2747-7699
Alexandra Stream *Department of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-0089-0552
Axel B JanssenDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-9865-447X
Paddy S GibsonDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Afonso M BravoDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Samira DaheshDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.
Jonathon L BakerDepartment of Oral Rehabilitation and Biosciences, School of Dentistry, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0001-5378-322X
Andrew VarbleSchool of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, USA.
Victor NizetDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-3847-0422
Jan-Willem VeeningDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-3162-6634

Funding

Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate ModelsR01AI173689 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Victor Nizet, Mark Joseph Walker · 2023 to 2026
$2.8M
Harnessing Broad-Specificity Phage Recombinases for Universal Bacterial Editing platformsDP2AI184732 · NIAID · UNIVERSITY OF ROCHESTER · PI Andrew Varble · 2024 to 2026
$1.4M
Investigating Membrane Alterations as a Mechanism of Acid Tolerance in Cariogenic BacteriaK99DE029228 · NIDCR · J. CRAIG VENTER INSTITUTE, INC. · PI BAKER, JONATHON · 2020 to 2022
$393k
NIAID NIH HHS DP2 AI184732NIAID NIH HHS R01 AI173689NIAID NIH HHS R37 AI052453NIDCR NIH HHS K99 DE029228Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) IZSEZ0_213879, 310030_192517, 310030_200792, 51NF40_180541Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) TMPFP3_210202
6 · The paper itself

Abstract

While genome-wide transposon mutagenesis screens have identified numerous essential genes in the significant human pathogen IMPORTANCE: While group A

Indexed as

CRISPR-Cas SystemsStreptococcal InfectionsStreptococcus pyogenesAnimalsBacterial ProteinsDisease Models, AnimalFemaleGene Expression Regulation, BacterialMiceVirulenceBacterial ProteinsCRISPRigenetic toolboxgroup A Streptococcusinfectious diseaseSpyBrowseStreptococcus pyogenes

Identifiers

PMID38953375
PMCPMC11323564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.